Quantcast

Latest Paracetamol Stories

2014-07-31 23:14:43

CR urges U.S. Food and Drug Administration to take stronger steps to reduce the dangers of pain-relief medications YONKERS, NY (PRWEB) July 31, 2014 Some pain relief medications can be as addictive as heroin and are rife with deadly side effects. Every day, 46 people in the U.S. die from legal pain pills and for each death, more than 30 people are admitted to an emergency room because of opioid complications. Consumer Reports has taken a close look at the dangers of prescription and...

2014-07-31 08:34:35

WASHINGTON, July 31, 2014 /PRNewswire-USNewswire/ -- Today's Consumer Reports story on prescription and non-prescription pain relievers serves as an important reminder for consumers of the importance of taking medicines safely and reinforces the importance of initiatives such as the Acetaminophen Awareness Coalition's (AAC) Know Your Dose consumer education campaign. Formed in 2010, the Coalition is a group of leading health, healthcare provider and consumer organizations dedicated to...

2014-07-30 08:33:40

LONDON, July 30, 2014 /PRNewswire/ -- Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), a biopharmaceutical company developing addiction treatments based on its expertise in opioid antagonists, announced today that it has received a funding commitment from a prominent international research and development foundation. The foundation has a focus on promoting innovative research-based initiatives, including those addressing health issues. Lightlake has been developing a nasal...

2014-07-29 23:01:49

The Firm is investigating Tylenol lawsuits on behalf of individuals who may have suffered serious liver damage due to the acetaminophen in Tylenol over-the-counter medications. New York, New York (PRWEB) July 29, 2014 Tylenol lawsuits (http://www.tylenollawsuitclaims.com/) filed on behalf of individuals who allegedly suffered serious liver injuries due to the acetaminophen in Tylenol-brand medications continue to move forward in a multidistrict litigation underway in U.S. District Court,...

2014-07-27 23:01:26

The Firm is investigating Tylenol lawsuits on behalf of individuals who allegedly suffered acetaminophen-induced liver damage due to Tylenol-brand over-the-counter products. New York, NY (PRWEB) July 27, 2014 As Tylenol lawsuits (http://www.tylenollawsuitclaims.com/) involving liver injuries continue to move forward in federal court, Bernstein Liebhard LLP notes that a new study is questioning one of the benefits purportedly associated with acetaminophen, the active ingredient in...

2014-07-25 10:45:39

The Lancet Paracetamol is no better than placebo at speeding recovery from acute episodes of lower back pain or improving pain levels, function, sleep, or quality of life, according to the first large randomised trial to compare the effectiveness of paracetamol with placebo for low-back pain. The findings, published in The Lancet, question the universal endorsement of paracetamol as the first choice painkiller for low-back pain, say the authors. Low-back pain is the leading cause of...

2014-07-12 23:01:33

The Firm is evaluating Tylenol lawsuits on behalf of individuals who allegedly suffered acetaminophen liver damage, allegedly due to Tylenol-brand medications. New York, New York (PRWEB) July 12, 2014 Tylenol lawsuits (http://www.tylenollawsuitclaims.com/) involving liver damage allegations continue to move forward in the federal multidistrict litigation underway in U.S. District Court, Eastern District of Pennsylvania, Bernstein Liebhard LLP reports. According to a filing dated July 1,...

2014-07-10 08:27:14

First and only FDA approved naloxone product specifically indicated for emergency therapy in settings where opioids may be present. RICHMOND, Va., July 10, 2014 /PRNewswire/ -- Kaleo, a privately-held pharmaceutical company headquartered in Richmond, Virginia, today announced the United States (U.S.) commercial availability of EVZIO for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression. EVZIO is not a...

2014-07-09 08:27:41

Name Change to Reflect the Operations of the Company after the Completion of the Public Transaction NEW YORK, July 9, 2014 /PRNewswire/ -- Camp Nine, Inc., (OTCBB: CMPE), a Nevada corporation which conducts its operations through Relmada Therapeutics, Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today that it has changed its corporate name to Relmada Therapeutics, Inc. The name change began with the Nevada Secretary of State...

2014-07-08 08:31:53

DUBLIN, July 8, 2014 /PRNewswire/ -- Perrigo Company (NYSE: PRGO; TASE) today announced that it was the first to receive final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for ibuprofen and phenylephrine hydrochloride tablets, 200 mg/10 mg (over-the-counter), the store brand equivalent to Advil(®) Congestion Relief Tablets, 200 mg/10 mg. Perrigo expects to begin shipments of the product prior to the upcoming cough/cold/flu season....


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'